Tenet Healthcare (THC) Tops Q4 EPS by 49c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Tenet Healthcare (THC) PT Lowered to $185 at Raymond James, 'Selloff After Quarter is Perplexing — Creates Attractive Entry Point Despite Policy Risks'
February 13, 2025 8:45 AM ESTRaymond James analyst John Ransom lowered the price target on Tenet Healthcare (NYSE: THC) to $185.00 (from $195.00) while maintaining a Outperform rating.
The analyst comments "We reiterate our Outperform rating on shares of THC while lowering our price target to $185 (8.5x 2026 EBITDA ex-NCI) following 4Q24 results that were slightly... More
